Researchers found a key difference in the brains of people with Alzheimer’s disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.
A new study has pinpointed a catalytic trigger for the onset of Alzheimer's disease. The findings could play a central role in the diagnostics and new drug development for neurodegenerative diseases.
A new study suggests amylin could be a second amyloid and a new biomarker for age related dementia and Alzheimer's disease.
Researchers have discovered how synthetic molecules latch onto amyloid peptide fibrils. The discovery could help develop new therapies to halt Alzheimer's disease.
With the help of the Gordon supercomputer, researchers discover new ways to elucidate the creation of oligomers associated with Alzheimer's.
A new study reports a molecular chaperone can inhibit a key stage in the development of Alzheimer's disease.
Raman spectroscopy techniques allows researchers to take a closer look at the elusive amyloid beta.
Researchers report a toxic form of tau protein increases following TBI, leading to the development of the same type of mental impairments seen in Alzheimer's patients.
Researchers made a subtle alteration to the amyloid beta protein. The change affect its aggregation behavior and stabilizes an intermediate form with enhanced toxicity.
A new study reports a computer simulation has been able to explore the initial steps of the molecular processes that lead to Alzheimer's disease.
Researchers have developed a new imaging technique that makes it possible to study why proteins associated with Alzheimer’s and Parkinson’s diseases may go from harmless to toxic.
A new paper details a technology that can detect pathological oligomeric forms of tau in Alzheimer's patients through human blood platelets.
